GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Inventories, Raw Materials & Components

ANTCF (Aion Therapeutic) Inventories, Raw Materials & Components : $0.00 Mil (As of Jan. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Aion Therapeutic Inventories, Raw Materials & Components?

Aion Therapeutic's inventories, raw materials & components for the quarter that ended in Jan. 2025 was $0.00 Mil.


Aion Therapeutic Inventories, Raw Materials & Components Historical Data

The historical data trend for Aion Therapeutic's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Inventories, Raw Materials & Components Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial - - - - -

Aion Therapeutic Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aion Therapeutic Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Aion Therapeutic Business Description

Industry
Traded in Other Exchanges
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.